COO vs DXCM: fair value comparison
The Cooper Companies, Inc. and DexCom, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COO currently sits closer to the top of our ranking by discount to fair value. DXCM carries the stronger quality grade.
| COO | DXCM | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $54.37 | $84.11 |
| 12-month range | $53.27–$84.32 | $54.84–$92.34 |
| Rank by discount to fair value | #8 of 108 Healthcare | #13 of 108 Healthcare |
| Quality grade | B | A |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: COO fair value analysis · DXCM fair value analysis